APA (7th ed.) Citation

Gonçalves, M., Matos, L., Santos, J. I., Coutinho, M. F., Prata, M. J., Pires, M. J., . . . Alves, S. (2022). Development of an antisense oligonucleotides-based therapy for mucolipidosis type II α/β: In vivo studies.

Chicago Style (17th ed.) Citation

Gonçalves, Mariana, Liliana Matos, Juliana Inês Santos, Maria Francisca Coutinho, Maria João Prata, Maria João Pires, Paula Oliveira, and Sandra Alves. Development of an Antisense Oligonucleotides-based Therapy for Mucolipidosis Type II α/β: In Vivo Studies. 2022.

MLA (8th ed.) Citation

Gonçalves, Mariana, et al. Development of an Antisense Oligonucleotides-based Therapy for Mucolipidosis Type II α/β: In Vivo Studies. 2022.